All Stories

  1. chlamydia trachomatis vaccine
  2. Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda
  3. Integration of HIV and cervical cancer screening perceptions and preferences of communities in Uganda
  4. Integration of HIV and cervical cancer screening perceptions of healthcare providers and policy makers in Uganda
  5. Prognostic impact of human papilloma virus (HPV) genotyping and HPV-16 subtyping in vaginal carcinoma
  6. Human Papillomavirus (HPV) and HPV 16–Variant Distribution in Vulvar Squamous Cell Carcinoma in Sweden